Jean-François Pariseau and Dion Madsen, Amplitude
November 6, 2019 10:45 AM ESTUpdated November 7, 01:33 AM
Financing

New Am­pli­tude fund looks to bet over $100 mil­lion on in­cip­i­ent Cana­di­an biotech mar­ket

Jason Mast

Editor

Two top Cana­di­an ven­ture cap­i­tal­ists and the Busi­ness De­vel­op­ment Bank of Cana­da have raised over $70 mil­lion for a new fund aimed sharply at fund­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times